“We are entering this next stage as our FDA-cleared portfolio continues to expand to support broader cardiac imaging workflows,” said Davidi Vortman, the company’s CEO and co-founder. | Read More in JPost.com – Business & Innovation | The Jerusalem Post
Trump’s trap: Solving Hormuz crisis saves Iranian regime, and threats don’t work – analysisNYT shareholders file lawsuit against paper’s parent org. over biased Israel reporting
Switzerland rejects asylum application from Iranian refugee pursuing Judaism
Canadian NDP leader slammed for Yom Kippur message claiming Jews failed ‘to stop ongoing genocide’
‘Everything we prepared for happened’: When IDF medics became casualties deep inside Syria
Power beneath the waves, threats of blockade: Israel Navy’s covert battle with its new submarine
‘We did not bend the knee’: Iran’s president hits back at US at UN
Police patrol crew member seriously wounded in West Bank ramming attack, terrorist killed
After Ra’am: Joint List disqualified from elections
Danon blasts Pezeshkian: ‘He should focus on his atrocities against the Iranian people’
US delegation walks out as Iranian President attacks Israel, US at UN
IDF reservist severely injured in ramming attack near Modi’inIsraeli-led firm developing AI-guided cardiac sonography raises $24 million to expand in US marketTrump’s Gaza plan is ready. The real challenge is making it happen – opinionTrump’s trap: Solving Hormuz crisis saves Iranian regime, and threats don’t work – analysisNYT shareholders file lawsuit against paper’s parent org. over biased Israel reporting